| ORIGINAL ARTICLE |
|
| Year : 2022 | Volume
: 36
| Issue : 3 | Page : 129-133 |
|
|
SARS-CoV-2 and Helicobacter pylori and some hematological parameters: A case–control study
Falah Hasan Obayes Al-Khikani1, Ahmed Danbous Obayes Al-Hussainy2, Aliaa Zaraa Allah Hussein3, Rasha Salih Mahdi Alshamary4
1 Department of Medical Laboratory Technology, College of Medical Technology, The Islamic University, Najaf; Department of Microbiology, Al-Shomali General Hospital, Babylon Health Directorate, Babylon University, Babylon, Iraq
2 Department of Pharmacy, Al-Mustaqbal University College, Babylon University, Babylon, Iraq
3 Department of Medical Microbiology, College of Medicine, Babylon University, Babylon, Iraq
4 Department of Seventh Life Laboratory, Marjan Hospital, Babylon, Iraq
Correspondence Address:
Dr. Falah Hasan Obayes Al-Khikani
Department of Medical Laboratory Technology, College of Medical Technology, The Islamic University, Najaf
Iraq
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/jms.jms_55_22
|
|
|
Background: The SARS-CoV-2 associated with bacterial infection represents a serious public health challenge. Recently, there is a remarkable increase in the number of researches that confirms the effect of Helicobacter pylori on pulmonary diseases.
Aim: The goal of this research was to see how H. pylori affected the presentation of COVID-19 infections as a prospective risk factor.
Materials and Methods: This research was conducted in Babylon, Iraq, from January 1, 2022, to March 5, 2022. A total of 180 people were engaged in this study, with 90 patients identified with SARS-CoV-2 by polymerase chain reaction testing and 90 people serving as a control group. Antibody screening assays on blood samples were used to look for antibodies against H. pylori. The samples were processed for complete blood count and ABO blood group.
Results: COVID-19 infection was more frequent in females than in males, especially between 31 and 45 years. When compared to healthy people, COVID-19 patients had a higher white blood cell count (P = 0.0001) and a lower lymphocyte count (P = 0.0001). H. pylori and COVID-19 have been found to have a strong relationship, especially in females. When comparing patients to healthy people, blood group A is the most common.
Conclusion: People with H. pylori infections are considerably more sensitive to COVID-19 than people without H. pylori infections (P = 0.011). In combination with SARS-CoV-2, IgG for H. pylori might be a risk factor.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
Next article
